Get the Daily Brief
Latest Biotech News
Novel AI and Multi-Omics Models Enhance Early Disease Prediction and Treatment
Breakthroughs in AI and multi-omics integration are enabling unprecedented accuracy in disease prediction and personalized medicine. A new AI model predicts preterm birth with nearly 90% accuracy...
Regulatory and Funding Landscape Reflect Optimism and Challenges in Biotech
Key industry updates highlight ongoing financial activities and regulatory decisions shaping biotech’s trajectory. Thermo Fisher inaugurated a new carbon-neutral manufacturing center in North...
AbbVie’s Psychedelic Drug Push: $1.2 Billion Gilgamesh Buyout
AbbVie has agreed to acquire Gilgamesh Pharmaceuticals’ lead psychedelic therapy candidate, bretisilocin, for up to $1.2 billion, consolidating its presence in neuroscience drug development. This...
FDA Suspends Valneva’s Chikungunya Vaccine Amid Safety Concerns
The U.S. Food and Drug Administration suspended the license of Valneva’s chikungunya vaccine, Ixchiq, following reports of serious adverse events linked to chikungunya-like illness in recipients....
Pig-to-Human Lung Transplant Shows Nine-Day Organ Viability
A landmark xenotransplantation milestone was achieved with the first pig-to-human lung transplant that remained viable and functional for nine days in a brain-dead patient. Using a genetically...
Illumina’s CEO Foresees Growth Despite Geopolitical and Funding Challenges
Illumina’s CEO Jacob Thaysen projects a return to steady annual growth by 2027, despite facing significant headwinds including a Chinese sales ban on sequencers and disruptions from U.S. trade...
AI Reveals Tuberculosis Drug Mechanisms for Faster Treatment Strategies
A recent study showcases the application of advanced AI-assisted molecular analysis to unravel how tuberculosis drugs kill bacteria, offering insights critical to developing faster and more...
Multi-Omics AI Model Achieves Near 90% Accuracy in Predicting Preterm Birth
Researchers have developed a cutting-edge artificial intelligence model integrating multi-omics data to predict preterm birth with nearly 90% accuracy. This significant breakthrough in...
Walgreens Boosts Clinical Trial Enrollment With Community-Based Approach
Walgreens’ clinical trials unit has successfully engaged over 17 million individuals, increasing patient enrollment rates by 20% over traditional referral methods. By establishing...
New Molecular Compound Advances Artificial Photosynthesis Techniques
A Swiss research team engineered a novel molecular donor-photosensitizer-acceptor compound that simultaneously stores two positive and two negative charges upon light absorption, marking a major...
Ultrack Tools Revolutionize Cell Tracking Across Biological Scales
The Chan Zuckerberg Biohub and collaborators have introduced Ultrack and inTRACKtive, integrated AI-powered tools offering unprecedented speed and accuracy for cell tracking across 2D, 3D, and...
Bacterial Peptide Corisin Identified as Driver of Diabetic Kidney Fibrosis
A gut microbiota-derived molecule, corisin, produced by Staphylococcus species, has been implicated in accelerating diabetic kidney fibrosis through mechanisms linked to cellular aging. This...
AbbVie Acquires Gilgamesh Psychedelic Therapy – Deals Heat Up in Psychedelic Space
AbbVie has agreed to purchase Gilgamesh Pharmaceuticals’ investigational psychedelic drug candidate bretisilocin for up to $1.2 billion, including upfront and milestone payments. This acquisition...
FDA Suspends License for Valneva’s Chikungunya Vaccine Amid Safety Concerns
The U.S. Food and Drug Administration has suspended the biologics license for Valneva’s chikungunya vaccine, Ixchiq, following reports of serious safety concerns including chikungunya-like illness...
Breakthrough in Pig-to-Human Lung Transplantation Extends Organ Viability
Pioneering work in xenotransplantation achieved a milestone with a genetically modified pig lung transplant into a brain-dead human patient, maintaining organ functionality for nine days. This...
Illumina Faces Market Headwinds but Sees Growth Pathway to 2027
Illumina is navigating significant regulatory and geopolitical challenges, including a ban on DNA sequencer sales in China and uncertainty stemming from U.S. trade tensions affecting academic...
AI and Computational Tools Advance Cancer and Cell Research
Innovations at the intersection of artificial intelligence and biology are dramatically improving cancer tissue analysis and cellular trajectory mapping. Mount Sinai researchers introduced MARQO,...
Novel Therapeutics and Drug Development Advances in Oncology
Recent research highlights promising new compounds and therapeutic strategies across oncology. PF-3758309 has been shown to cause RNA polymerase II degradation, presenting a novel anti-tumor...
Gut Microbiome and Metabolite Roles in Kidney Disease Progression
Emerging studies elucidate microbial influences on kidney fibrosis and diabetic kidney disease (DKD). Peptide corisin, secreted by gut Staphylococcus species, accelerates kidney fibrosis via...
Multi-Omics and AI Models Enhance Disease Prediction and Personalized Medicine
Innovative AI-integrated multi-omics approaches are significantly improving disease risk prediction and personalized therapy. A novel AI model combining diverse omics datasets achieved almost 90%...